Cargando…
Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review
Visceral leishmaniasis (VL) is the most lethal of all leishmaniasis diseasesand the second most common parasiticdisease after malaria and,still, categorized as a neglected tropical disease (NTD). According to the latest WHO study, >20 Leishmania species spread 0.7–1.0 million new cases of leishma...
Autores principales: | Kumar, Prakash, Kumar, Pawan, Singh, Nidhi, Khajuria, Salil, Patel, Rahul, Rajana, Vinod Kumar, Mandal, Debabrata, Velayutham, Ravichandiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794769/ https://www.ncbi.nlm.nih.gov/pubmed/36588956 http://dx.doi.org/10.3389/fbioe.2022.1016925 |
Ejemplares similares
-
Enhanced AmB Production in Streptomyces nodosus by Fermentation Regulation and Rational Combined Feeding Strategy
por: Zhang, Bo, et al.
Publicado: (2020) -
The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review
por: Kumar, Prakash, et al.
Publicado: (2022) -
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
por: Moradi, Seyed Zachariah, et al.
Publicado: (2020) -
Selective Cytotoxic Activity of Prodigiosin@halloysite Nanoformulation
por: Guryanov, Ivan, et al.
Publicado: (2020) -
A Superstable Homogeneous Lipiodol-Nanoformulation to Overcome the Dilemma of Interventional Embolization Chemotherapy
por: Peng, Yisheng, et al.
Publicado: (2022)